Clinimark: 2nd Conference Validation of Biomarkers

“Translating biomarker candidates from discovery to the clinic remains a challenge. This second symposium organised by the Clinimark project will examine how integrated technologies can bridge the innovation gap with an initial focus on lung diseases.”

KEYNOTE SPEAKER

Joseph Menetski, PhD. Associate Vice President of Research Partnerships – Director of the Biomarkers Consortium, the Foundation for the National Institutes of Health, USA

SCIENTIFIC TOPICS

• Biomarker research and development
• Biomarker validation process and techniques
• Biomarker FDA regulation
• Pulmonary Diseases including COPD, oncology, cystic fibrosis
• Biobanking and data stewardship
• Technologies (mass spectrometry, multiplex immunoassays, new approaches to quantify proteins in body fluids and breath condensate)

WHO SHOULD ATTEND?

• Clinicians
• Clinical chemists
• Biologists (molecular biology, biochemistry, epidemiology)
• Scientists with an interest in biomarker technology
• Industrial scientists (start-up, diagnostic, pharmaceutical, biotechnological)